We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

44 hedge funds and large institutions have $23.6M invested in Cumberland Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 10

2% more capital invested

Capital invested by funds: $23.2M → $23.6M (+$420K)

8% less funds holding

Funds holding: 48 → 44 (-4)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
44
Holders Change
-4
Holders Change %
-8.33%
% of All Funds
1.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
12
Reduced
10
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$590K
2
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
+$95.7K
3
AI
Ariel Investments
Illinois
+$73K
4
Renaissance Technologies
Renaissance Technologies
New York
+$58.2K
5
EGA
Eagle Global Advisors
Texas
+$30.4K

Top Sellers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
-$218K
2
SLG
Stanley-Laman Group
Pennsylvania
-$158K
3
CCM
Coldstream Capital Management
Washington
-$70K
4
PP
PDT Partners
New York
-$68K
5
GCP
GSA Capital Partners
United Kingdom
-$60K
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
1
Ariel Investments
Illinois
$8.97M +$73K +15,942 +0.8%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$3.83M -$9.18K -2,004 -0.2%
BIT
3
BlackRock Institutional Trust
California
$1.72M -$218K -47,595 -11%
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.34M +$11.9K +2,600 +0.9%
BCM
5
Bridgeway Capital Management
Texas
$1.25M – – –
New York State Common Retirement Fund
6
New York State Common Retirement Fund
New York
$1.24M +$95.7K +20,900 +8%
Renaissance Technologies
7
Renaissance Technologies
New York
$1.06M +$58.2K +12,700 +6%
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
$613K +$536 +117 +0.1%
SCM
9
Stonepine Capital Management
Oregon
$580K +$590K +128,798 New
BA
10
Bard Associates
Illinois
$424K +$1.56K +340 +0.4%
EGA
11
Eagle Global Advisors
Texas
$376K +$30.4K +6,639 +9%
UCFA
12
United Capital Financial Advisors
Texas
$364K +$1.74K +380 +0.5%
Invesco
13
Invesco
Georgia
$334K -$18.3K -4,000 -5%
California Public Employees Retirement System
14
California Public Employees Retirement System
California
$242K – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$216K – – –
Morgan Stanley
16
Morgan Stanley
New York
$169K -$13.3K -2,901 -7%
SIM
17
Spark Investment Management
New York
$152K -$58.2K -12,700 -27%
BFA
18
BlackRock Fund Advisors
California
$143K -$2.85K -622 -2%
Northern Trust
19
Northern Trust
Illinois
$115K -$39.3K -8,589 -25%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$96K – – –
Jacobs Levy Equity Management
21
Jacobs Levy Equity Management
New Jersey
$63K – – –
Citadel Advisors
22
Citadel Advisors
Florida
$58K +$7.66K +1,671 +15%
DAM
23
Delta Asset Management
Tennessee
$55K – – –
JAM
24
JW Asset Management
Florida
$49K – – –
Cambridge Investment Research Advisors
25
Cambridge Investment Research Advisors
Iowa
$45K – – –
1
2

CPIX Hedge Fund Activity: Q2 2016 in Review

44 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q2 2016, worth a combined $23.6M — up 1.8% from $23.2M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of CPIX and 4 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 12 added.

The largest buyer was Stonepine Capital Management, opening a new position worth an estimated $590K. The largest seller was BlackRock Institutional Trust, cutting an estimated $218K.

  • 44 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q2 2016, down from 48 in Q1 2016.
  • Funds reported $23.6M of Cumberland Pharmaceuticals stock for Q2 2016, up 1.8% quarter-over-quarter.
  • 4 funds opened new Cumberland Pharmaceuticals positions in Q2 2016 and 7 closed out, a net change of -3 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q2 2016 was Stonepine Capital Management, an estimated $590K added.
  • The largest Cumberland Pharmaceuticals seller in Q2 2016 was BlackRock Institutional Trust, an estimated $218K sold.

Based on aggregated 13F filings for Q2 2016.